NCT03001765View on ClinicalTrials.gov

Impact of an Intensive Monitoring Strategy in Symptomatic Patients With Suspected Arrhythmia

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Suspected Arrhythmia
Interventions
OTHER

"Intensive Monitoring Strategy: Reveal LINQ™ Insertable Cardiac Monitoring System."

Intensive monitoring strategy of discharge from Emergency Department with 30 day SEEQ external monitor, followed by implantable cardiac Reveal LINQ monitor if negative 30 day result.

Trial Locations (1)

41017

St. Elizabeth Healthcare, Edgewood

All Listed Sponsors
lead

St Elizabeth Healthcare

OTHER

NCT03001765 - Impact of an Intensive Monitoring Strategy in Symptomatic Patients With Suspected Arrhythmia | Biotech Hunter | Biotech Hunter